C. Ward < C. Warren Olanow < C. Waterman

Facettes :

List of bibliographic references

Number of relevant bibliographic references: 32.
[0-20] [0 - 20][0 - 32][20-31][20-40]

Ident.	Authors (with country if any)	Title
000118 (2008)	C. Warren Olanow ; Karl Kieburtz ; Anthony H. V. Schapira	Why have we failed to achieve neuroprotection in Parkinson's disease?
000205 (2008)	Anthony H. V. Schapira ; C. Warren Olanow	Drug selection and timing of initiation of treatment in early Parkinson's disease
000217 (2008)	C. Warren Olanow ; Robert A. Hauser ; Joseph Jankovic ; William Langston ; Anthony Lang ; Werner Poewe ; Eduardo Tolosa ; Fabrizio Stocchi ; Eldad Melamed ; Eli Eyal ; Olivier Rascol	A randomized, double‐blind, placebo‐controlled, delayed start study to assess rasagiline as a disease modifying therapy in Parkinson's disease (the ADAGIO study): Rationale, design, and baseline characteristics
000241 (2011)	C. Warren Olanow ; Kathryn B. Wunderle ; Karl Kieburtz	Milestones in movement disorders clinical trials: Advances and landmark studies
000250 (2002)	Ira Shoulson ; David Oakes ; Stanley Fahn ; Anthony Lang ; J. William Langston ; Peter Lewitt ; C. Warren Olanow ; John B. Penney ; Caroline Tanner ; Karl Kieburtz ; Alice Rudolph	Impact of sustained deprenyl (selegiline) in levodopa‐treated Parkinson's disease: A randomized placebo‐controlled extension of the deprenyl and tocopherol antioxidative therapy of parkinsonism trial
000302 (2005)	C. Warren Olanow ; Joseph Jankovic	Neuroprotective therapy in Parkinson's disease and motor complications: A search for a pathogenesis‐targeted, disease‐modifying strategy
000324 (2010)	Fabrizio Stocchi ; Olivier Rascol ; Karl Kieburtz ; Werner Poewe ; Joseph Jankovic ; Eduardo Tolosa ; Paulo Barone ; Anthony E. Lang ; C. Warren Olanow	Initiating levodopa/carbidopa therapy with and without entacapone in early Parkinson disease: The STRIDE‐PD study
000683 (2008)	C. Warren Olanow	Levodopa/dopamine replacement strategies in Parkinson's disease—Future directions
000723 (2008)	Fabrizio Stocchi ; Michele Tagliati ; C. Warren Olanow	Treatment of levodopa‐induced motor complications
000842 (2003)	Fabrizio Stocchi ; C. Warren Olanow	Neuroprotection in Parkinson's disease: Clinical trials
000B67 (2010)	C. Warren Olanow ; Karl Kieburtz	Defining disease‐modifying therapies for PD—A road map for moving forward
000C13 (2007)	C. Warren Olanow	The pathogenesis of cell death in Parkinson's disease – 2007
000D92 (1995)	Thomas B. Freeman ; Paul R. Sanberg ; G. Michael Nauert ; Barbara D. Boss ; Dennis Spector ; C. Warren Olanow ; Jeffrey H. Kordower	The influence of donor age on the survival of solid and suspension intraparenchymal human embryonic nigral grafts
000E60 (2009)	C. Warren Olanow ; Jeffrey H. Kordower ; Anthony E. Lang ; Jose A. Obeso	Dopaminergic transplantation for parkinson's disease: Current status and future prospects
000E71 (2011)	C. Warren Olanow ; K. Mcnaught	Parkinson's disease, proteins, and prions: Milestones
001015 (1997)	Koller ; Rajesh Pahwa ; Karen Busenbark ; Jean Hubble ; Steve Wilkinson ; Anthony Lang ; Paul Tuite ; Elspeth Sime ; Andres Lazano ; Robert Hauser ; Teresita Malapira ; Donald Smith ; Daniel Tarsy ; Edison Miyawaki ; Thorkild Norregaard ; Theresa Kormos ; C. Warren Olanow	High‐frequency unilateral thalamic stimulation in the treatment of essential and parkinsonian tremor
001328 (2002)	Fabrizio Stocchi ; Stefano Ruggieri ; Laura Vacca ; C. Warren Olanow	Prospective randomized trial of lisuride infusion versus oral levodopa in patients with Parkinson’s disease
001498 (2003)	Kevin St. P. Mcnaught ; C. Warren Olanow	Proteolytic stress: A unifying concept for the etiopathogenesis of Parkinson's disease
001531 (2000)	José A. Obeso ; C. Warren Olanow ; John G. Nutt	Levodopa motor complications in Parkinson's disease
001976 (2011)	Thomas D. H Lbig ; Stephanie Assuras ; Judy Creighton ; Joan C. Borod ; Winona Tse ; Pasquale G. Frisina ; Andrei Voustianiouk ; Jean-Michel Gracies ; C. Warren Olanow	Differential role of dopamine in emotional attention and memory: Evidence from Parkinson's disease
001983 (2004)	C. Warren Olanow ; Yves Agid ; Yoshi Mizuno ; Alberto Albanese ; U. Bonucelli ; Philip Damier ; Justo De Yebenes ; Oscar Gershanik ; Mark Guttman ; F. Grandas ; Mark Hallett ; Ole Hornykiewicz ; Peter Jenner ; R. Katzenschlager ; William J. Langston ; Peter Lewitt ; Eldad Melamed ; M. A. Mena ; P. P. Michel ; Catherine Mytilineou ; Jose A. Obeso ; Werner Poewe ; Niall Quinn ; R. Raisman-Vozari ; Ali H. Rajput ; Olivier Rascol ; Christina Sampaio ; Fabrizio Stocchi	Levodopa in the treatment of Parkinson's disease: Current controversies

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonV1/Data/Main/Corpus

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Corpus/Author.i -k "C. Warren Olanow" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Corpus/Author.i  \
                -Sk "C. Warren Olanow" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Corpus/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    ParkinsonV1
   |flux=    Main
   |étape=   Corpus
   |type=    indexItem
   |index=    Author.i
   |clé=    C. Warren Olanow
}}

---

This area was generated with Dilib version V0.6.23. Data generation: Sun Jul 3 18:06:51 2016. Site generation: Wed Mar 6 18:46:03 2024